# Abbott Laboratories (ABT) SEC filings: 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/ABT/filings

> Abbott Laboratories (ABT) SEC filings from EDGAR: 10-K filed Feb 20, 2026, 10-Q filed Nov 4, 2026, 8-K filed Nov 16, 2026. 118 filings in the last 12 months.

---

## Abbott Laboratories (ABT) SEC filings

Abbott Laboratories's latest annual report is a Form 10-K filed on February 20, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on November 4, 2026. Its latest current report, a Form 8-K, was filed on November 16, 2026. EDGAR lists 118 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 10-K, Feb 20, 2026
- **Latest quarterly report:** 10-Q, Nov 4, 2026
- **Latest 8-K:** 8-K, Nov 16, 2026
- **Filings, last 12 months:** 118
- **Insider forms, last 12 months:** 71 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 3
- **SEC central index key:** 0000001800

Filings as listed by SEC EDGAR at Nov 18, 2026, 10:07 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000001800](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000001800). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Abbott Laboratories: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htm) | Nov 4, 2026 | Sep 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm) | Jul 28, 2026 | Jun 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/abt-20260331.htm) | Apr 29, 2026 | Mar 31, 2026 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm) | Feb 20, 2026 | Dec 31, 2025 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/abt-20250930.htm) | Oct 29, 2025 | Sep 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/abt-20250630.htm) | Jul 30, 2025 | Jun 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/abt-20250331.htm) | Apr 30, 2025 | Mar 31, 2025 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/abt-20241231.htm) | Feb 21, 2025 | Dec 31, 2024 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/abt-20240930.htm) | Oct 31, 2024 | Sep 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/abt-20240630.htm) | Jul 31, 2024 | Jun 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/abt-20240331.htm) | May 2, 2024 | Mar 31, 2024 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/abt-20231231.htm) | Feb 16, 2024 | Dec 31, 2023 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/abt-20230930.htm) | Nov 1, 2023 | Sep 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/abt-20230630.htm) | Aug 3, 2023 | Jun 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/abt-20230331.htm) | May 4, 2023 | Mar 31, 2023 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/abt-20221231.htm) | Feb 17, 2023 | Dec 31, 2022 | Annual report |

The latest 16 of 34 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

Abbott Laboratories: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926127273/tm2629582d1_8k.htm) | Nov 16, 2026 | Nov 11, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926117587/tm2627971d1_8k.htm) | Oct 21, 2026 | Oct 21, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-20261021.htm) | Oct 21, 2026 | Oct 21, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926099247/tm2623675d1_8k.htm) | Aug 20, 2026 | Aug 20, 2026 | 7.01 Regulation FD Disclosure 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026048377/abt-20260716.htm) | Jul 16, 2026 | Jul 16, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm) | Apr 27, 2026 | Apr 24, 2026 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 Submission of Matters to a Vote of Security Holders 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926044892/tm2611915d1_8k.htm) | Apr 17, 2026 | Apr 10, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026025365/abt-20260416.htm) | Apr 16, 2026 | Apr 16, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926033079/tm268709d2_8k.htm) | Mar 23, 2026 | Mar 23, 2026 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926025240/tm264905d8_8k.htm) | Mar 9, 2026 | Mar 9, 2026 | 1.01 Entry into a Material Definitive Agreement 2.03 Creation of a Direct Financial Obligation 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926020509/tm264905d7_8k.htm) | Feb 26, 2026 | Feb 23, 2026 | 1.01 Entry into a Material Definitive Agreement 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/tm266807d1_8k.htm) | Feb 20, 2026 | Feb 20, 2026 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026002982/abt-20260122.htm) | Jan 22, 2026 | Jan 22, 2026 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925120657/tm2533113d1_8k.htm) | Dec 12, 2025 | Dec 12, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925114995/tm2531676d1_8k.htm) | Nov 21, 2025 | Nov 18, 2025 | 5.04 Temporary Suspension of Trading Under Registrant's Employee Benefit Plans 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925114422/tm2531676d2_8k.htm) | Nov 20, 2025 | Nov 19, 2025 | 1.01 Entry into a Material Definitive Agreement 7.01 Regulation FD Disclosure 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828025045049/abt-20251015.htm) | Oct 15, 2025 | Oct 15, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000162828025035135/abt-20250717.htm) | Jul 17, 2025 | Jul 17, 2025 | 2.02 Results of Operations and Financial Condition 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925043508/tm2513718d1_8k.htm) | May 1, 2025 | Apr 25, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925040201/tm2513267d1_8k.htm) | Apr 28, 2025 | Apr 25, 2025 | 5.07 Submission of Matters to a Vote of Security Holders |

The latest 20 of 90 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

Abbott Laboratories: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 1 |
| Oct 2026 | 5 |
| Sep 2026 | 3 |
| Aug 2026 | 2 |
| Jul 2026 | 6 |
| Jun 2026 | 2 |
| May 2026 | 0 |
| Apr 2026 | 20 |
| Mar 2026 | 12 |
| Feb 2026 | 11 |
| Jan 2026 | 5 |
| Dec 2025 | 3 |

Abbott Laboratories: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000178314726000013/xslF345X06/form4-11062026_101139.xml) | Nov 6, 2026 | Nov 5, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000110465926113291/xslF345X06/tm2626917-5_4seq1.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000110465926113287/xslF345X06/tm2626917-4_4seq1.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000110465926113286/xslF345X06/tm2626917-3_4seq1.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000110465926113285/xslF345X06/tm2626917-2_4seq1.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000110465926113280/xslF345X06/tm2626917-1_4seq1.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000130611926000009/xslF345X06/form4-09252026_090910.xml) | Sep 25, 2026 | Sep 23, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000164420726000012/xslF345X06/form4-09032026_100920.xml) | Sep 3, 2026 | Sep 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000180509926000008/xslF345X06/form4-09032026_100959.xml) | Sep 3, 2026 | Sep 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/xslF345X06/form4-08272026_090838.xml) | Aug 27, 2026 | Aug 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000186766626000013/xslF345X06/form4-08132026_090844.xml) | Aug 13, 2026 | Aug 11, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000138526226000019/xslF345X06/form4-07012026_100703.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000157754426000010/xslF345X06/form4-07012026_090744.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000187970126000008/xslF345X06/form4-07012026_090745.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000130611926000006/xslF345X06/form4-07012026_090707.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000210271526000006/xslF345X06/form4-07012026_090738.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000186766626000009/xslF345X06/form4-07012026_090726.xml) | Jul 1, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000207537126000009/xslF345X06/form4-06292026_090621.xml) | Jun 29, 2026 | Jun 27, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000138526226000017/xslF345X06/form4-06182026_090625.xml) | Jun 18, 2026 | May 7, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/1800/000178314726000009/xslF345X06/form4-04292026_090456.xml) | Apr 29, 2026 | Apr 28, 2026 |

The latest 20 of 742 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

Abbott Laboratories: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1800/000210011926000151/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 29, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000010290926000500/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 26, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000010290925000355/xslSCHEDULE_13G_X01/primary_doc.xml) | Dec 3, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465924020156/tv0163-abbottlaboratories.htm) | Feb 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000108636424004264/us0028241000_012624.txt) | Jan 26, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465923015184/tv0146-abbottlaboratories.htm) | Feb 9, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000130655023007894/us0028241000_020623.txt) | Feb 6, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465922016351/tv0137-abbottlaboratories.htm) | Feb 9, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000083423722003867/us0028241000_013122.txt) | Feb 1, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000142284821000090/SEC13G_Filing.htm) | Feb 16, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465921017319/tv0109-abbottlaboratories.htm) | Feb 10, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000083423721002898/us0028241000_012821.txt) | Jan 29, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000142284820000005/edgabt.txt) | Feb 14, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465920018176/tv01477-abbottlaboratories.htm) | Feb 12, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000083423720004596/us0028241000_020420.txt) | Feb 5, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000110465919008110/a19-4270_1sc13ga.htm) | Feb 14, 2019 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/1800/000142284819000007/edgabt.txt) | Feb 14, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000093247119004200/abbottlaboratories.htm) | Feb 11, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/1800/000021545719003128/us0028241000_020419.txt) | Feb 4, 2019 | — |

Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

Abbott Laboratories: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000130817926000065/a2026abbottlaboratoriesna.htm) | Mar 13, 2026 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000130817926000064/abt-20260311.htm) | Mar 13, 2026 | Apr 24, 2026 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000130817925000135/abt012575_defa14a.htm) | Mar 14, 2025 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000130817925000134/abt012575_def14a.htm) | Mar 14, 2025 | Apr 25, 2025 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000130817924000183/abt4257331-defa14a.htm) | Mar 15, 2024 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000130817924000182/abt4257331-def14a.htm) | Mar 15, 2024 | Apr 26, 2024 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000130817923000248/abt4116441_defa14a.htm) | Mar 17, 2023 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000130817923000247/abt4116441-def14a.htm) | Mar 17, 2023 | — | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000120677422000779/abt3910011-defa14a.htm) | Mar 18, 2022 | — | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000120677422000778/abt3910011-def14a.htm) | Mar 18, 2022 | Apr 29, 2022 | DEFINITIVE PROXY STATEMENT |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000110465921035570/a21-2277_7defa14a.htm) | Mar 12, 2021 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000104746921000592/a2242988zdef14a.htm) | Mar 12, 2021 | Apr 23, 2021 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/1800/000104746921000455/a2242893zpre14a.htm) | Feb 25, 2021 | Apr 23, 2021 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000110465920046440/tm2015275d1_defa14a.htm) | Apr 14, 2020 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000110465920033146/a19-18502_7defa14a.htm) | Mar 13, 2020 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000104746920001466/a2240611zdef14a.htm) | Mar 13, 2020 | Apr 24, 2020 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/1800/000110465919015302/a18-36770_10defa14a.htm) | Mar 15, 2019 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/1800/000104746919001316/a2237648zdef14a.htm) | Mar 15, 2019 | Apr 26, 2019 | Definitive proxy statement |

**Everything else (99 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Abbott Laboratories: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000178314726000011/xsl144X01/primary_doc.xml) | Nov 5, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000164420726000010/xsl144X01/primary_doc.xml) | Sep 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000161257126000008/xsl144X01/primary_doc.xml) | Aug 25, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000186766626000011/xsl144X01/primary_doc.xml) | Aug 11, 2026 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/1800/000110465926075724/abt-20251231x11k.htm) | Jun 18, 2026 | Dec 31, 2025 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/1800/000110465926066986/tm2615656d1_sd.htm) | May 27, 2026 | — | FORM SD |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000144807426000012/xsl144X01/primary_doc.xml) | May 15, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000144807426000010/xsl144X01/primary_doc.xml) | Apr 27, 2026 | — | Notice of proposed sale |
| [S-8](https://www.sec.gov/Archives/edgar/data/1800/000110465926048560/tm2612167d1_s8.htm) | Apr 24, 2026 | — | FORM S-8 |
| [S-8](https://www.sec.gov/Archives/edgar/data/1800/000110465926033413/tm268709d1_s8.htm) | Mar 23, 2026 | — | FORM S-8 |
| [ARS](https://www.sec.gov/Archives/edgar/data/1800/000130817926000066/abt014387_arsa.pdf) | Mar 13, 2026 | Dec 31, 2025 | ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000205812926000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000162056426000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000186766626000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000178314726000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000164420726000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000207537126000005/xsl144X01/primary_doc.xml) | Mar 2, 2026 | — | Notice of proposed sale |
| [424B5](https://www.sec.gov/Archives/edgar/data/1800/000110465926019401/tm264905-5_424b5.htm) | Feb 25, 2026 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/1800/000110465926018708/tm264905d6_fwp.htm) | Feb 24, 2026 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/1800/000110465926018399/tm264905-3_424b3.htm) | Feb 23, 2026 | — | Prospectus |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/1800/000110465926018381/tm264905-1_s3asr.htm) | Feb 23, 2026 | — | Short-form registration statement |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000205812925000007/xsl144X01/primary_doc.xml) | Nov 25, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000110465925075773/xsl144X01/primary_doc.xml) | Aug 8, 2025 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925061154/tm2518166d1_11k.htm) | Jun 20, 2025 | Dec 31, 2024 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/1800/000000180025000006/a2024formsdandcmrfinal.htm) | May 29, 2025 | — | Specialized disclosure report |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000195004725002617/xsl144X01/primary_doc.xml) | Apr 30, 2025 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/1800/000130817925000136/abt012575-ars.pdf) | Mar 14, 2025 | Dec 31, 2024 | ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925007450/xsl144X01/primary_doc.xml) | Mar 7, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925007278/xsl144X01/primary_doc.xml) | Mar 6, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925006320/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925006300/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925006297/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925006292/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925006290/xsl144X01/primary_doc.xml) | Mar 3, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925003153/xsl144X01/primary_doc.xml) | Feb 5, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925002408/xsl144X01/primary_doc.xml) | Jan 30, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925002407/xsl144X01/primary_doc.xml) | Jan 30, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588925002279/xsl144X01/primary_doc.xml) | Jan 29, 2025 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314124000531/xsl144X01/primary_doc.xml) | Nov 4, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314124000510/xsl144X01/primary_doc.xml) | Oct 21, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924023317/xsl144X01/primary_doc.xml) | Sep 12, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314124000441/xsl144X01/primary_doc.xml) | Sep 4, 2024 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/1800/000110465924074741/tm2417608d1_11k.htm) | Jun 25, 2024 | Dec 31, 2023 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/1800/000110465924066637/tm2415127d1_sd.htm) | May 30, 2024 | — | FORM SD |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000110465924059971/xsl144X01/primary_doc.xml) | May 10, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924012537/xsl144X01/primary_doc.xml) | May 7, 2024 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/1800/000130817924000184/abt_2023annualreport.pdf) | Mar 15, 2024 | Dec 31, 2023 | ANNUAL REPORT TO SECURITY HOLDERS |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006166/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006154/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006151/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006147/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006139/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000141588924006136/xsl144X01/primary_doc.xml) | Mar 1, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314124000126/xsl144X01/primary_doc.xml) | Feb 23, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314124000050/xsl144X01/primary_doc.xml) | Jan 29, 2024 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314123000342/xsl144X01/primary_doc.xml) | Dec 14, 2023 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314123000258/xsl144X01/primary_doc.xml) | Oct 26, 2023 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314123000175/xsl144X01/primary_doc.xml) | Aug 8, 2023 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314123000158/xsl144X01/primary_doc.xml) | Jul 27, 2023 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/1800/000197314123000157/xsl144X01/primary_doc.xml) | Jul 26, 2023 | — | Notice of proposed sale |

The latest 60 of 99 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form PRE 14A — Preliminary proxy statement**

A preliminary proxy statement subject to review by the SEC staff.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

**Form SD — Specialized disclosure report**

In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Abbott Laboratories's latest annual report (10-K)?**

Abbott Laboratories filed its latest Form 10-K with the SEC on February 20, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did Abbott Laboratories file its latest 10-Q?**

On November 4, 2026 for the period ended September 30, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has Abbott Laboratories reported on Form 8-K recently?**

Its latest 8-K was filed on November 16, 2026 (5.02 Departure or Election of Directors or Officers; Officer Compensation). In the last twelve months the items it reported most often were: 8.01 Other Events (5 reports); 2.02 Results of Operations and Financial Condition (4 reports); 1.01 Entry into a Material Definitive Agreement (3 reports). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for ABT in the last year?**

71 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 6, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Abbott Laboratories?**

EDGAR lists 3 Schedule 13D or 13G filings about Abbott Laboratories in the last twelve months, the latest on April 29, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Abbott Laboratories (ABT) SEC filings: 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
